MedTrace Logo

Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital

NCT01981876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305

Last updated 2015-02-27

No results posted yet for this study

Summary

Esophageal squamous cell cancer (ESCC) is common in the developing world, and is the leading cancer diagnosis at Tenwek Hospital in southwestern Kenya. The investigators long-term goal is to understand the pathogenesis and risk factors for ESCC in Kenya, and to establish effective screening and prevention programs. The investigators hypothesize that asymptomatic esophageal squamous dysplasia (ESD) is common in their region, and the current protocol is designed to determine the prevalence of ESD in residents of southwestern Kenya.

Conditions

  • Esophageal Dysplasia

Sponsors & Collaborators

  • Kenyatta National Hospital

    collaborator OTHER_GOV

  • Mayo Clinic

    collaborator OTHER

  • AORTIC

    collaborator UNKNOWN

  • Tenwek Hospital

    lead OTHER

Principal Investigators

  • Michael M Mwachiro, MBChB · Tenwek Hospital

  • Russ E White, MD · Tenwek Hospital

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01981876 on ClinicalTrials.gov